Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

Immune checkpoint inhibitors provide considerable therapeutic benefit in a range of solid cancers as well as in a subgroup of hematological malignancies. Response rates are however suboptimal, and despite considerable efforts, predicting response to immune checkpoint inhibitors ahead of their admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893879/
https://www.ncbi.nlm.nih.gov/pubmed/33602280
http://dx.doi.org/10.1186/s13046-021-01872-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893879/
https://www.ncbi.nlm.nih.gov/pubmed/33602280
http://dx.doi.org/10.1186/s13046-021-01872-3

Ejemplares similares